Area of research
Epidemiology · Hepatology
Research interest
Research interests include Hepatitis B Virus Studies, Hepatitis C virus research, Nanoplatforms for cancer theranostics, and Nanoparticle-Based Drug Delivery.
Efficacy and safety of GLS4 with entecavir vs entecavir alone in chronic hepatitis B patients: A multicenter clinical trial
[Safety profile of tenofovir amibufenamide therapy extension or switching in patients with chronic hepatitis B: a phase Ⅲ multicenter, randomized controlled trial].
Restoring neuronal iron homeostasis revitalizes neurogenesis after spinal cord injury
Engineering Poly(ethylene glycol) Nanoparticles for Accelerated Blood Clearance Inhibition and Targeted Drug Delivery
Association between the nasopharyngeal microbiome and metabolome in patients with COVID-19
Targeting Mitochondria-Located circRNA SCAR Alleviates NASH via Reducing mROS Output
Recurrence of positive SARS-CoV-2 RNA in COVID-19: A case report
Polypeptide-Based Theranostics with Tumor-Microenvironment-Activatable Cascade Reaction for Chemo-ferroptosis Combination Therapy
Self-assembly of paramagnetic amphiphilic copolymers for synergistic therapy
Eco-Friendly, Self-Healing Hydrogels for Adhesive and Elastic Strain Sensors, Circuit Repairing, and Flexible Electronic Devices
Homozygous p.Ser267Phe in SLC10A1 is associated with a new type of hypercholanemia and implications for personalized medicine
Tunable assembly and disassembly of responsive supramolecular polymer brushes
The 104-week efficacy and safety of telbivudine-based optimization strategy in chronic hepatitis B patients: A randomized, controlled study